Fundraising Fox
Paratek Pharmaceuticals
Boston, US · Founded 1996 · 474 employees on LinkedIn · 1 known investors
Find your way into Paratek Pharmaceuticals
Sign up to see every warm intro you have to Paratek Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paratek Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Paratek Pharma develops and commercializes specialty therapies for patients with life-threatening infectious diseases and difficult-to-treat conditions. The company's pipeline includes FDA-approved antibiotics and other pharmaceutical products targeting areas of unmet medical need.
Founders & leadership
EL
Evan LohExecutive
BA
Beverly ArmstrongExecutive
SK
S. Ken TanakaExecutive
MB
Michael BighamExecutive
Board
RL
Richard LimBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$93M disclosed across 1 round · 2014
▶$93MraisedJul 2014 · 54 investors · PharmaceuticalsRule 506(b)
▶$93MraisedJul 2014 · 54 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Evan LohExecutive Officer, Director
- Sean M. JohnstonExecutive Officer
- Beverly ArmstrongExecutive Officer
- Richard LimDirector
- Dennis MolnarExecutive Officer
- Kathryn BoxmeyerExecutive Officer
- S. Ken TanakaExecutive Officer
- Michael BighamExecutive Officer, Director
- Offering amount
- $93M
- Amount sold
- $93M
- Sales commissions
- $2.5M
- Placement agents
- Trout Capital LLC, Ladenburg Thalmann & Co. Inc.
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Paratek Pharmaceuticals do?
- Paratek Pharma develops and commercializes specialty therapies for patients with life-threatening infectious diseases and difficult-to-treat conditions. The company's pipeline includes FDA-approved antibiotics and other pharmaceutical products targeting areas of unmet medical need.
- Who are Paratek Pharmaceuticals's investors?
- Paratek Pharmaceuticals's investors include Aisling Capital.
- How much funding has Paratek Pharmaceuticals raised?
- Paratek Pharmaceuticals has disclosed $93M raised across 1 round.
- Where is Paratek Pharmaceuticals headquartered?
- Paratek Pharmaceuticals is headquartered in Boston, US.